These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27904506)

  • 1. Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials.
    Guillermin A; Yan DJ; Perrier A; Marti C
    Arch Med Sci; 2016 Dec; 12(6):1181-1187. PubMed ID: 27904506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
    Li HY; Wang YB; Ren XY; Wang J; Wang HS; Jin YH
    Pharmacology; 2023; 108(2):111-126. PubMed ID: 36603558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.
    Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K
    Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Ahmed S; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2018 Nov; 46(4):440-450. PubMed ID: 30117036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review.
    Dundar Y; Hill R; Dickson R; Walley T
    QJM; 2003 Feb; 96(2):103-13. PubMed ID: 12589008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction.
    Dunn CJ; Goa KL
    Am J Cardiovasc Drugs; 2001; 1(1):51-66. PubMed ID: 14728052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials.
    Kobeissi H; Ghozy S; Turfe B; Bilgin C; Kadirvel R; Kallmes DF; Brinjikji W; Rabinstein AA
    Front Neurol; 2023; 14():1102463. PubMed ID: 36756249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
    Jinatongthai P; Kongwatcharapong J; Foo CY; Phrommintikul A; Nathisuwan S; Thakkinstian A; Reid CM; Chaiyakunapruk N
    Lancet; 2017 Aug; 390(10096):747-759. PubMed ID: 28831992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of tenecteplase in acute myocardial infarction.
    Guerra DR; Karha J; Gibson CM
    Expert Opin Pharmacother; 2003 May; 4(5):791-8. PubMed ID: 12740001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review.
    Potla N; Ganti L
    Int J Emerg Med; 2022 Jan; 15(1):1. PubMed ID: 34983359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety of tenecteplase and alteplase in acute ischemic stroke: A pairwise and network meta-analysis of randomized controlled trials.
    Rehman AU; Mohsin A; Cheema HA; Zahid A; Ebaad Ur Rehman M; Ameer MZ; Ayyan M; Ehsan M; Shahid A; Aemaz Ur Rehman M; Shah J; Khawaja A
    J Neurol Sci; 2023 Feb; 445():120537. PubMed ID: 36630803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
    ; Van De Werf F; Adgey J; Ardissino D; Armstrong PW; Aylward P; Barbash G; Betriu A; Binbrek AS; Califf R; Diaz R; Fanebust R; Fox K; Granger C; Heikkilä J; Husted S; Jansky P; Langer A; Lupi E; Maseri A; Meyer J; Mlczoch J; Mocceti D; Myburgh D; Oto A; Paolasso E; Pehrsson K; Seabra-Gomes R; Soares-Piegas L; Sùgrue D; Tendera M; Topol E; Toutouzas P; Vahanian A; Verheugt F; Wallentin L; White H
    Lancet; 1999 Aug; 354(9180):716-22. PubMed ID: 10475182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world comparative safety and efficacy of tenecteplase
    Psychogios K; Palaiodimou L; Katsanos AH; Magoufis G; Safouris A; Kargiotis O; Spiliopoulos S; Papageorgiou E; Theodorou A; Voumvourakis K; Broutzos E; Stamboulis E; Tsivgoulis G
    Ther Adv Neurol Disord; 2021; 14():1756286420986727. PubMed ID: 33488774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis.
    Oliveira M; Fidalgo M; Fontão L; Antão J; Marques S; Afreixo V; Gregório T
    Am J Emerg Med; 2021 Apr; 42():31-37. PubMed ID: 33440328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis.
    Ma P; Zhang Y; Chang L; Li X; Diao Y; Chang H; Hui L
    J Neurol; 2022 Oct; 269(10):5262-5271. PubMed ID: 35776193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis.
    Katsanos AH; Psychogios K; Turc G; Sacco S; de Sousa DA; De Marchis GM; Palaiodimou L; Filippou DK; Ahmed N; Sarraj A; Menon BK; Tsivgoulis G
    JAMA Netw Open; 2022 Mar; 5(3):e224506. PubMed ID: 35357458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenecteplase versus alteplase for large vessel occlusion recanalization (T-FLAVOR): Trial protocol.
    Kawano H; Hirano T; Inoue M; Fukuda-Doi M; Iwasaki K; Omae K; Tanaka K; Yamamoto H; Koga M; Sakai N; Nagao T; Sasaki M; Hayakawa N; Toyoda K
    Eur Stroke J; 2022 Mar; 7(1):71-75. PubMed ID: 35300254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase versus Alteplase for the Management of Acute Ischemic Stroke in a Low-income Country-Nepal: Cost, Efficacy, and Safety.
    Nepal G; Kharel G; Ahamad ST; Basnet B
    Cureus; 2018 Feb; 10(2):e2178. PubMed ID: 29651371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.